Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 April 2019 | Story Xolisa Mnukwa | Photo Vhugala Nthakheni
Uhuru Qwaqwa Arrival
The #UFSWalkToUhuru team arrives at the UFS Qwaqwa Campus on Friday 22 March.

The University of the Free State (UFS) Division of Student Affairs, in collaboration with the UFS Office for International Affairs, have joined hands to drive a fundraising and student-accessibility initiative dubbed, ‘The Walk to Uhuru’ (#UFSWalktoUhuru), which is aimed at raising funds and advocating for the educational rights of the less privileged. 

The project aims to raise funds in excess of R2 million from the public and stakeholders affiliated with the UFS (Kovsie staff and students). The project derives from the 2018/2019 UFS Institutional Student Representative Council (ISRC) mandate ‘Students Must Graduate’. The ISRC mandate aims to source funding opportunities for UFS students to register, and to complete their studies across all three campuses in 2020 and beyond.

The first leg of the project, a 350 km walk from the Bloemfontein to the Qwaqwa Campus, has already taken place and concluded on Friday, 22 March 2019 as planned. The #UFSWalkToUhuru team successfully completed the first leg of their journey to academic freedom for financially disadvantaged students at the UFS. The Uhuru team is now focusing its attention on the second leg and is determined to take on Mount Kilimanjaro (Uhuru) from 20 June to 20 July 2019.

The team sat down for a debriefing session to unpack the overall experience and result of the first half of the initiative, and they all agreed that the walk to Qwaqwa was an enlightening experience. It was a walk that comprised learning opportunities, team building, and goal crushing.

According to Rethabile Motseki, member of the #UFSWalkToUhuru team, the walk to Qwaqwa made a significant impact on the project, as the university community is now aware of the significant goals that the team is trying to accomplish. The team has also resumed their fitness-training programme to ensure that they are ready to take on the Uhuru climb in June.

A media briefing will take place shortly (date to be confirmed) to detail the ongoing fundraising initiatives rolled out by the #UFSWalkToUhuru team.  We implore you, and the nation as a whole, to help establish a better future for disadvantaged UFS students by donating to the initiative.

Students, staff, and the public can support the cause and make contributions/donations to the initiative by visiting the UFS Walk to Uhuru #givengain account page.

For more information, contact UFS SRC President, Sonwabile Dwaba, on DwabaSJ@ufs.ac.za  or Rethabile Motseki on MotsekiR@ufs.ac.za  

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept